Visual, Refractive And Patient Reported Outcomes With A Toric Enhanced Monofocal Intraocular Lens In A Real World Setting
Published 2024 - 42nd Congress of the ESCRS
Reference: PP10.13 | Type: Free paper | DOI: 10.82333/tq4q-wr69
Authors: David Teenan 1 , Stephen Hannan* 1 , Jan Venter 1 , Sandro DiSimplicio 1 , Igor Occhipinti 1
1Optical Express,Glasgow,United Kingdom
Purpose
To report the clinical and patient reported outcomes with the TECNIS Eyhance Toric II intraocular lens in patients with preoperative corneal astigmatism.
Setting
Private Refractive Surgery (Optical Express)
Methods
Outcomes of 617 patients who underwent Lens Replacement surgery in the presence or absence of a cataract with bilateral implantation of the TECNIS Eyhance Toric II lens were reviewed. Age range of patients was 40 to 92 years with up to 6.75D of corneal astigmatism and 8.50D of manifest astigmatism. Postoperative clinical and patient-reported outcomes were analysed.
Results
Percent of patient eyes with postoperative manifest cylinder ≤1.00D was 91.8%, with 62.6% ≤0.50D. Mean UCDVA was +0.03 logMAR, UCIVA was +0.18 logMAR and UCNVA was +0.42 logMAR. After lens settled, 87.2% had <5° of rotation vs the intended axis. Less than 7% of patients experienced severe difficulty with quality of vision. Over 90% of patients reported being satisfied or very satisfied with outcome and would recommend treatment to family and friends. Posterior capsular opacification was noted in 6.2% of patient eyes; while 1 patient eye recorded posterior capsule rupture with no vitreous loss, and no patients reported endophthalmitis or toxic anterior segment syndrome.
Conclusions
Initial outcomes suggest this Toric II IOL is a good option for patients with preoperative corneal astigmatism who would benefit from functional intermediate distance vision postoperatively. The vast majority of implants had a high level of rotational stability. Visual outcomes were positive and well received, while severe visual phenomena remains very low.